| 201109-1G |
|
NA |
(11aS)-3,7-Bis([1,1':3',1''-terphenyl]-5'-yl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C57H47O4P |
|
|
|
| 201109-100MG |
|
NA |
(11aS)-3,7-Bis([1,1':3',1''-terphenyl]-5'-yl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C57H47O4P |
|
|
|
| 201109-25MG |
|
NA |
(11aS)-3,7-Bis([1,1':3',1''-terphenyl]-5'-yl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C57H47O4P |
|
|
|
| 201108-1G |
|
NA |
(11aR)-3,7-Bis([1,1':3',1''-terphenyl]-5'-yl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C57H47O4P |
|
|
|
| 201108-100MG |
|
NA |
(11aR)-3,7-Bis([1,1':3',1''-terphenyl]-5'-yl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C57H47O4P |
|
|
|
| 201108-25MG |
|
NA |
(11aR)-3,7-Bis([1,1':3',1''-terphenyl]-5'-yl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C57H47O4P |
|
|
|
| 201107-1G |
|
NA |
(11aS)-3,7-Bis(triphenylsilyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C57H51O4PSi2 |
|
|
|
| 201107-100MG |
|
NA |
(11aS)-3,7-Bis(triphenylsilyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C57H51O4PSi2 |
|
|
|
| 201107-25MG |
|
NA |
(11aS)-3,7-Bis(triphenylsilyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C57H51O4PSi2 |
|
|
|
| 201106-1G |
|
NA |
(11aR)-3,7-Bis(triphenylsilyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C57H51O4PSi2 |
|
|
|
| 201106-100MG |
|
NA |
(11aR)-3,7-Bis(triphenylsilyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C57H51O4PSi2 |
|
|
|
| 201106-25MG |
|
NA |
(11aR)-3,7-Bis(triphenylsilyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C57H51O4PSi2 |
|
|
|
| 201105-1G |
|
NA |
(11aS)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C33H27Cl4O4P |
|
|
|
| 201105-100MG |
|
NA |
(11aS)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C33H27Cl4O4P |
|
|
|
| 201105-25MG |
|
NA |
(11aS)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C33H27Cl4O4P |
|
|
|
| 201104-1G |
|
NA |
(11aR)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C33H27Cl4O4P |
|
|
|
| 201104-100MG |
|
NA |
(11aR)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C33H27Cl4O4P |
|
|
|
| 201104-25MG |
|
NA |
(11aR)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C33H27Cl4O4P |
|
|
|
| 201103-1G |
|
NA |
(11aS)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C33H29N2O8P |
|
|
|
| 201103-100MG |
|
NA |
(11aS)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C33H29N2O8P |
|
|
|
